Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of ...

Pacira BioSciences, Inc. (NASDAQ:PCRX) received FDA clearance to market a new Smart Tip designed to access the medial branch ...

Nalu Medical, Inc. (“Nalu”), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use of Nalu PNS therapy in chronic pain patients ...

The use of facet median nerve branch radiofrequency ablation ... There are multiple applications of pulsed RFA in the treatment of chronic pain.

A single-center retrospective study in China found a significant association between pain duration and intensity in patients ...

Changes in the brain with cortical reorganisation to gut stimulation and increased activity in specific electroencephalographic features characteristic for neuropathic pain are also seen in patients ...

For people suffering from chronic knee pain, especially those over 50, a new treatment is offering hope and relief.

This new medication, unlike many existing treatments, is not an opioid. Early tests on rats show it effectively reduces pain without causing harmful side effects. Chronic nerve pain, or ...

Drugs which have been studied include: Tricyclic antidepressants were considered the standard treatment for depression before SSRIs were developed. While these drugs are now used less often for ...

On Power Athlete Radio Episode 745, Dr. Adeel Khan shed light on the pitfalls of conventional pain management options and emphasized the transformative potentia ...

Pacira BioSciences PCRX announced that the FDA has cleared its application to market a new Smart Tip for the iovera system ...